Literature DB >> 7662969

Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice.

E J Boland1, Y C Liu, C A Walter, D C Herbert, F J Weaker, M W Odom, P Jagadeeswaran.   

Abstract

Factor IX (FIX), a circulating serine protease that serves as an essential component of the blood coagulation pathway, has been shown to increase with age in humans. We show here that murine FIX mRNA and activity levels also increase with age. Furthermore, one form of hemophilia B, hemophilia B Leyden, which is caused by mutations within the promoter region of the FIX gene, has a distinct age-dependent phenotype. To determine the source of the age-related increases in FIX gene expression, we have analyzed the regulation of the normal FIX gene promoter and FIX Leyden gene promoter with the +13 mutation during aging by generating transgenic mice that contain the -189 to +21 bp promoter segment ligated to a chloramphenicol acetyltransferase reporter gene. We have established that the normal FIX promoter and the Leyden promoter transgenes are expressed in a tissue-specific manner in vivo. The normal FIX promoter transgene does not show any differences in the pattern of expression with age or sex of the organism, whereas the Leyden promoter transgene showed age-dependent male-specific expression. This is the first demonstration of the FIX Leyden phenotype in a transgenic mouse model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662969

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.

Authors:  Sumiko Kurachi; Jeffrey S Huo; Afshin Ameri; Kezhong Zhang; Akiyasu C Yoshizawa; Kotoku Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

Review 2.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Hereditary thrombophilia.

Authors:  Salwa Khan; Joseph D Dickerman
Journal:  Thromb J       Date:  2006-09-12

4.  Diagnosis and phenotypic assessment of Pakistani Haemophilia B carriers.

Authors:  Muhammad Tariq Masood Khan; Arshi Naz; Jawad Ahmed; Tahir Sultan Shamsi; Abid Sohail Taj
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

5.  A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden.

Authors:  Alister P W Funnell; Michael D Wilson; Benoit Ballester; Ka Sin Mak; Jon Burdach; Natisha Magan; Richard C M Pearson; Frederic P Lemaigre; Kathryn M Stowell; Duncan T Odom; Paul Flicek; Merlin Crossley
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.